NO179325C - Indolderivater - Google Patents
IndolderivaterInfo
- Publication number
- NO179325C NO179325C NO924829A NO924829A NO179325C NO 179325 C NO179325 C NO 179325C NO 924829 A NO924829 A NO 924829A NO 924829 A NO924829 A NO 924829A NO 179325 C NO179325 C NO 179325C
- Authority
- NO
- Norway
- Prior art keywords
- lower alkyl
- denotes
- cis
- indole derivatives
- amino
- Prior art date
Links
- 229940054051 antipsychotic indole derivative Drugs 0.000 title abstract 2
- 150000002475 indoles Chemical class 0.000 title abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 5
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 abstract 1
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003435 aroyl group Chemical group 0.000 abstract 1
- 125000005239 aroylamino group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 208000010877 cognitive disease Diseases 0.000 abstract 1
- 125000004122 cyclic group Chemical group 0.000 abstract 1
- 125000005462 imide group Chemical group 0.000 abstract 1
- 230000006993 memory improvement Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH380691 | 1991-12-20 | ||
| CH325492 | 1992-10-19 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| NO924829D0 NO924829D0 (no) | 1992-12-14 |
| NO924829L NO924829L (no) | 1993-06-21 |
| NO179325B NO179325B (no) | 1996-06-10 |
| NO179325C true NO179325C (no) | 1996-09-18 |
Family
ID=25692569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO924829A NO179325C (no) | 1991-12-20 | 1992-12-14 | Indolderivater |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US5318966A (enExample) |
| EP (1) | EP0548664B1 (enExample) |
| JP (1) | JPH07119215B2 (enExample) |
| CN (1) | CN1037510C (enExample) |
| AT (1) | ATE123277T1 (enExample) |
| AU (1) | AU661076B2 (enExample) |
| BG (1) | BG61186B1 (enExample) |
| CA (1) | CA2084442A1 (enExample) |
| CZ (1) | CZ381092A3 (enExample) |
| DE (1) | DE59202406D1 (enExample) |
| DK (1) | DK0548664T3 (enExample) |
| ES (1) | ES2073847T3 (enExample) |
| FI (1) | FI925774A7 (enExample) |
| GR (1) | GR3017256T3 (enExample) |
| HU (2) | HUT68178A (enExample) |
| IL (1) | IL104080A (enExample) |
| IS (1) | IS3961A (enExample) |
| MY (1) | MY108026A (enExample) |
| NO (1) | NO179325C (enExample) |
| NZ (1) | NZ245463A (enExample) |
| TW (1) | TW239127B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE152708T1 (de) * | 1989-07-13 | 1997-05-15 | Upjohn Co | (1,2n) und (3,2n)-karbozyklische-2-amino- tetralinderivate |
| US5486611A (en) * | 1989-07-13 | 1996-01-23 | The Upjohn Company | Carboxamido-(1,2N)-carbocyclic-2-aminotetralin derivatives |
| CA2073340C (en) * | 1990-01-11 | 1997-05-20 | Hakan Vilhelm Wikstrom | Centrally acting 6,7,8,9-tetrahydro-3h-benz(e)indole heterocyclics |
| US5434170A (en) * | 1993-12-23 | 1995-07-18 | Andrulis Pharmaceuticals Corp. | Method for treating neurocognitive disorders |
| NZ290199A (en) * | 1994-07-27 | 1999-06-29 | Sankyo Co | Nitrogen containing heterocyclic compounds, selective allosteric effectors to regulate m1 receptors |
| US5859295A (en) * | 1994-12-05 | 1999-01-12 | University Of Kentucky Research Foundation | Canavanine analogs and their use as chemotherapeutic agents |
| IL117149A0 (en) * | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
| US5889006A (en) * | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
| GB9612153D0 (en) * | 1996-06-11 | 1996-08-14 | Smithkline Beecham Plc | Compounds |
| EP2963041A1 (en) * | 2014-07-02 | 2016-01-06 | Laboratorios Del. Dr. Esteve, S.A. | Tricyclic triazolic compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1277789A (en) * | 1969-09-08 | 1972-06-14 | Logeais Labor Jacques | Improvements in or relating to new polycyclic pyrrole derivatives |
| JPS4930836B1 (enExample) * | 1971-07-22 | 1974-08-16 | ||
| JPS4916862A (enExample) * | 1972-06-14 | 1974-02-14 | ||
| SE8004002L (sv) * | 1980-05-29 | 1981-11-30 | Arvidsson Folke Lars Erik | Terapeutiskt anvendbara tetralinderivat |
| SE8302361D0 (sv) * | 1983-04-27 | 1983-04-27 | Astra Laekemedel Ab | New tricyclic amines |
| CA2051399C (en) * | 1989-05-31 | 2003-12-30 | Chiu-Hong Lin | Therapeutically useful 2-aminotetralin derivatives |
| ATE152708T1 (de) * | 1989-07-13 | 1997-05-15 | Upjohn Co | (1,2n) und (3,2n)-karbozyklische-2-amino- tetralinderivate |
-
1992
- 1992-11-27 TW TW081109528A patent/TW239127B/zh active
- 1992-12-03 CA CA002084442A patent/CA2084442A1/en not_active Abandoned
- 1992-12-09 DE DE59202406T patent/DE59202406D1/de not_active Expired - Fee Related
- 1992-12-09 EP EP92120925A patent/EP0548664B1/de not_active Expired - Lifetime
- 1992-12-09 DK DK92120925.0T patent/DK0548664T3/da active
- 1992-12-09 AT AT92120925T patent/ATE123277T1/de active
- 1992-12-09 ES ES92120925T patent/ES2073847T3/es not_active Expired - Lifetime
- 1992-12-14 HU HU9203956A patent/HUT68178A/hu unknown
- 1992-12-14 HU HU9203956A patent/HU9203956D0/hu unknown
- 1992-12-14 IL IL104080A patent/IL104080A/xx not_active IP Right Cessation
- 1992-12-14 NO NO924829A patent/NO179325C/no unknown
- 1992-12-14 NZ NZ245463A patent/NZ245463A/en unknown
- 1992-12-15 AU AU30186/92A patent/AU661076B2/en not_active Ceased
- 1992-12-18 FI FI925774A patent/FI925774A7/fi not_active Application Discontinuation
- 1992-12-18 MY MYPI92002338A patent/MY108026A/en unknown
- 1992-12-18 IS IS3961A patent/IS3961A/is unknown
- 1992-12-18 BG BG97201A patent/BG61186B1/bg unknown
- 1992-12-19 CN CN92114640A patent/CN1037510C/zh not_active Expired - Fee Related
- 1992-12-21 CZ CS923810A patent/CZ381092A3/cs unknown
- 1992-12-21 JP JP4355382A patent/JPH07119215B2/ja not_active Expired - Lifetime
-
1993
- 1993-07-16 US US08/093,412 patent/US5318966A/en not_active Expired - Fee Related
- 1993-09-03 US US08/118,831 patent/US5318967A/en not_active Expired - Fee Related
-
1995
- 1995-08-30 GR GR950402372T patent/GR3017256T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JPH06128228A (ja) | 1994-05-10 |
| NZ245463A (en) | 1995-05-26 |
| US5318967A (en) | 1994-06-07 |
| DK0548664T3 (da) | 1995-09-04 |
| DE59202406D1 (de) | 1995-07-06 |
| IS3961A (is) | 1993-06-21 |
| CN1037510C (zh) | 1998-02-25 |
| GR3017256T3 (en) | 1995-11-30 |
| NO179325B (no) | 1996-06-10 |
| HUT68178A (en) | 1995-05-29 |
| CN1088576A (zh) | 1994-06-29 |
| BG97201A (bg) | 1993-12-24 |
| JPH07119215B2 (ja) | 1995-12-20 |
| BG61186B1 (bg) | 1997-02-28 |
| ATE123277T1 (de) | 1995-06-15 |
| AU661076B2 (en) | 1995-07-13 |
| EP0548664A1 (de) | 1993-06-30 |
| FI925774L (fi) | 1993-06-21 |
| HU9203956D0 (en) | 1993-03-29 |
| NO924829D0 (no) | 1992-12-14 |
| EP0548664B1 (de) | 1995-05-31 |
| FI925774A0 (fi) | 1992-12-18 |
| NO924829L (no) | 1993-06-21 |
| IL104080A0 (en) | 1993-05-13 |
| CZ381092A3 (en) | 1993-09-15 |
| CA2084442A1 (en) | 1993-06-21 |
| AU3018692A (en) | 1993-06-24 |
| ES2073847T3 (es) | 1995-08-16 |
| IL104080A (en) | 1997-04-15 |
| MY108026A (en) | 1996-07-30 |
| FI925774A7 (fi) | 1993-06-21 |
| TW239127B (enExample) | 1995-01-21 |
| US5318966A (en) | 1994-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO941052L (no) | Benzimidazolforbindelser, deres anvendelse og fremstilling | |
| HUT61543A (en) | Process for producing serotonin antagonist indole derivatives and pharmaceutical compositions comprising same as active ingredient | |
| ES8801247A1 (es) | Un procedimiento para la preparacion de nuevos derivados de carbazolona | |
| DK0632036T3 (da) | Amidderivater med antipypercholesteræmisk aktivitet, deres fremstilling og deres terapeutiske anvendelser | |
| MY131641A (en) | Indoline derivatives, process of preparation and use | |
| HUT62889A (en) | Process for producing benzoisothiazole and benzoisoxazole-3-carboxamide derivatives and pharmaceutical compositions comprising such compounds as active ingredient | |
| DE69216293D1 (de) | 1,4-Disubstituierte Piperidinderivate, ihre Herstellung und therapeutische Verwendung | |
| ATE123277T1 (de) | 2,3,3a,4,5,9b-hexahydro-1h-benzo(e>indol- derivate. | |
| SE8307119D0 (sv) | Carboxylic acid amides and their derivatives | |
| ES2132284T3 (es) | Derivados de carbamato de 2-(piperidin-4-il, piridin-4-il y tetrahidropiridin-4-il)-benzofurano-7, su preparacion y su uso como inhibidores de acetilcolinesterasa. | |
| UY23624A1 (es) | Procedimiento para la preparacion de nuevos derivados de indol | |
| DK213290D0 (da) | Treatment of cerebrovascular disorders | |
| DE69227088D1 (de) | Verwendung von 1-(aminoalkyl)-3-Quinoxalin-2-on Derivaten zur Herstellung von neuroprotektiven Mitteln | |
| NO20062599L (no) | Fremgangsmate for syntese av perindopril og farmasoytisk akseptable salter derav | |
| CA2200742A1 (en) | Quinoxaline derivatives useful in therapy | |
| FI103887B (fi) | Menetelmä terapeuttisesti käyttökelpoisten imidatsolyylimetyyli-pyridiinien valmistamiseksi | |
| NO983285D0 (no) | Pyrido-1,2,4-tiadiazin- og pyrido-1,4-tiazinderivater, deres fremstilling og anvendelse | |
| YU9893A (sr) | Derivati indola | |
| DE69432000D1 (de) | Verwendung von Tetrahydropyridinderivaten zur Herstellung von Kardioprotektiven Medikamenten | |
| DK0573360T3 (da) | Pyrrolothienopyrazinforbindelser som 5-HT3-receptorantagonister |